{"id":"https://openalex.org/W1968162177","doi":"https://doi.org/10.2337/dc07-2118","title":"Impact of Disease Management on Utilization and Adherence With Drugs and Tests","display_name":"Impact of Disease Management on Utilization and Adherence With Drugs and Tests","alternate_titles":[],"publication_year":2008,"publication_date":"2008-06-07","ids":{"openalex":"https://openalex.org/W1968162177","doi":"https://doi.org/10.2337/dc07-2118","mag":"1968162177","pmid":"https://pubmed.ncbi.nlm.nih.gov/18523144","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2518331"},"language":"en","primary_location":{"id":"doi:10.2337/dc07-2118","doi":"https://doi.org/10.2337/dc07-2118","is_oa":true,"landing_page_url":"https://doi.org/10.2337/dc07-2118","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1968162177"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.2337/dc07-2118","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073582194","display_name":"Patrick Thiebaud","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Patrick Thiebaud","raw_affiliation_strings":["From Pfizer Health Solutions, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Pfizer Health Solutions, New York, New York","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067411636","display_name":"Michael Demand","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael Demand","raw_affiliation_strings":["From Pfizer Health Solutions, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Pfizer Health Solutions, New York, New York","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079325055","display_name":"Scott A. Wolf","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Scott A. Wolf","raw_affiliation_strings":["From Pfizer Health Solutions, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Pfizer Health Solutions, New York, New York","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051601589","display_name":"Linda Line Alipuria","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Linda L. Alipuria","raw_affiliation_strings":["From Pfizer Health Solutions, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Pfizer Health Solutions, New York, New York","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103130333","display_name":"Qin Ye","orcid":"https://orcid.org/0000-0002-2191-3568","observed_orcids":["https://orcid.org/0000-0002-2191-3568"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Qin Ye","raw_affiliation_strings":["From Pfizer Health Solutions, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Pfizer Health Solutions, New York, New York","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111513986","display_name":"Peter R. Gutierrez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter R. Gutierrez","raw_affiliation_strings":["From Pfizer Health Solutions, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Pfizer Health Solutions, New York, New York","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5073582194"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":null,"apc_paid":null,"fwci":2.1406,"has_fulltext":true,"cited_by_count":25,"citation_normalized_percentile":{"value":0.87301151,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"31","issue":"9","first_page":"1717","last_page":"1722"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10793","display_name":"Diabetes Management and Education","score":0.5410000085830688,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10793","display_name":"Diabetes Management and Education","score":0.5410000085830688,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.42750000953674316,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12246","display_name":"Chronic Disease Management Strategies","score":0.009700000286102295,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diabetes-management","display_name":"diabetes management","score":0.8980000019073486},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.953000009059906},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.9150000214576721},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.8799999952316284},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9810000061988831},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":1.0},{"id":"https://openalex.org/keywords/laboratory-test-utilization","display_name":"laboratory test utilization","score":0.6959999799728394},{"id":"https://openalex.org/keywords/a1c-testing","display_name":"A1C testing","score":0.7630000114440918},{"id":"https://openalex.org/keywords/lipid-testing","display_name":"lipid testing","score":0.9330000281333923},{"id":"https://openalex.org/keywords/medicaid","display_name":"Medicaid","score":0.5770000219345093},{"id":"https://openalex.org/keywords/insulin-use","display_name":"insulin use","score":0.6830000281333923},{"id":"https://openalex.org/keywords/health-care-utilization","display_name":"health care utilization","score":0.4189999997615814}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9381976127624512},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6477096080780029},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5692641735076904},{"id":"https://openalex.org/C2982889124","wikidata":"https://www.wikidata.org/wiki/Q107439039","display_name":"Disease management","level":4,"score":0.5573978424072266},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4592738747596741},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.43522605299949646},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2926585078239441},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.07927906513214111},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D003925","descriptor_name":"Diabetic Angiopathies","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005431","descriptor_name":"Florida","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007407","descriptor_name":"Interviews as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008329","descriptor_name":"Managed Care Programs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008484","descriptor_name":"Medicaid","qualifier_ui":"Q000458","qualifier_name":"organization & administration","is_major_topic":false},{"descriptor_ui":"D008484","descriptor_name":"Medicaid","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013689","descriptor_name":"Telephone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014652","descriptor_name":"Vascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D017048","descriptor_name":"Health Care Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017723","descriptor_name":"Drug Utilization Review","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019090","descriptor_name":"Case Management","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044469","descriptor_name":"Racial Groups","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.2337/dc07-2118","doi":"https://doi.org/10.2337/dc07-2118","is_oa":true,"landing_page_url":"https://doi.org/10.2337/dc07-2118","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2518331","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2518331/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2518331/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"Text"},{"id":"pmid:18523144","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18523144","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes care","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.274.5249","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.274.5249","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/2d/1e/Diabetes_Care_2008_Sep_31(9)_1717-1722.tar.gz","raw_type":"text"}],"best_oa_location":{"id":"doi:10.2337/dc07-2118","doi":"https://doi.org/10.2337/dc07-2118","is_oa":true,"landing_page_url":"https://doi.org/10.2337/dc07-2118","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1968162177.pdf","grobid_xml":"https://content.openalex.org/works/W1968162177.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W137489616","https://openalex.org/W1609399188","https://openalex.org/W1974384610","https://openalex.org/W1993187958","https://openalex.org/W2000445173","https://openalex.org/W2009531939","https://openalex.org/W2057112394","https://openalex.org/W2059158127","https://openalex.org/W2059764669","https://openalex.org/W2062379203","https://openalex.org/W2078868398","https://openalex.org/W2096212914","https://openalex.org/W2114878544","https://openalex.org/W2124435663","https://openalex.org/W2137665561","https://openalex.org/W2139634859","https://openalex.org/W2145355470","https://openalex.org/W2154062944","https://openalex.org/W2164215771","https://openalex.org/W2171233776","https://openalex.org/W2769264260","https://openalex.org/W4210559565","https://openalex.org/W4231349462"],"related_works":["https://openalex.org/W2164215771","https://openalex.org/W3012000337","https://openalex.org/W2145988183","https://openalex.org/W2305138165","https://openalex.org/W2162247758","https://openalex.org/W1981750272","https://openalex.org/W2157330130","https://openalex.org/W4288026265","https://openalex.org/W1747701377"],"abstract_inverted_index":{"OBJECTIVE:":[0],"The":[1,110,227],"purpose":[2],"of":[3,11,50,112],"this":[4],"study":[5],"was":[6,125],"to":[7,23,106,145,239,245],"evaluate":[8],"the":[9,128],"effect":[10],"telephonic":[12,76,229],"care":[13,77,96,113,230],"management":[14,19,71,78,114,231],"within":[15],"a":[16,41,67],"diabetes":[17,54,238],"disease":[18,70],"program":[20],"on":[21,102,115],"adherence":[22,118,162,244,256],"treatment":[24,146,241],"with":[25,53,127,237],"hypoglycemic":[26,171,209,247],"agents,":[27],"ACE":[28],"inhibitors":[29],"(ACEIs),":[30],"angiotensin":[31],"receptor":[32],"blockers":[33],"(ARBs),":[34],"statins,":[35],"and":[36,91,117,123,150,165,184,198,217,242,249],"recommended":[37,250],"laboratory":[38],"tests":[39,124],"in":[40,61,133,161],"Medicaid":[42,69,235],"population.":[43],"RESEARCH":[44],"DESIGN":[45],"AND":[46],"METHODS:":[47],"A":[48,63],"total":[49],"2,598":[51,107],"patients":[52,236],"enrolled":[55],"for":[56,85,120,138,182,193,202],"at":[57,86,147],"least":[58,87],"2":[59],"years":[60],"Florida:":[62],"Healthy":[64],"State":[65],"(FAHS),":[66],"large":[68],"program,":[72],"who":[73,140,152],"received":[74],"individualized":[75],"were":[79,83,99,135,141,153],"selected":[80],"if":[81],"they":[82],"eligible":[84],"12":[88,92],"months":[89,93],"before":[90],"after":[94],"beginning":[95],"management.":[97],"Patients":[98],"matched":[100],"one-to-one":[101],"all":[103],"baseline":[104,148,164,258],"characteristics":[105],"control":[108],"patients.":[109],"impact":[111],"utilization":[116,134],"rates":[119],"diabetes-related":[121],"medications":[122],"analyzed":[126],"difference-in-difference":[129],"estimator.":[130],"RESULTS:":[131],"Changes":[132],"evaluated":[136],"separately":[137],"those":[139,151],"characterized":[142],"as":[143],"adherent":[144],"(\"users\")":[149],"not":[154],"(\"nonusers\").":[155],"Both":[156],"groups":[157],"achieved":[158],"significant":[159],"improvement":[160],"between":[163],"follow-up.":[166],"Nonusers":[167],"increased":[168,208],"their":[169],"overall":[170],"use":[172,210,219],"by":[173,179,190,199,211,220],"0.7":[174,180,200],"script":[175,181,222],"(P":[176,195,204,214,223],"<":[177,188,196,205,215,224],"0.001),":[178,189,197],"ACEIs":[183],"statins":[185],"(both":[186],"P":[187],"0.8":[191],"test":[192,201],"A1C":[194],"lipids":[203],"0.001).":[206,225],"Users":[207],"1.5":[212],"scripts":[213],"0.001)":[216],"insulin":[218,259],"0.9":[221],"CONCLUSIONS:":[226],"FAHS":[228],"intervention":[232],"effectively":[233],"induced":[234],"begin":[240],"improved":[243,255],"oral":[246],"agents":[248],"tests.":[251],"It":[252],"also":[253],"substantially":[254],"among":[257],"users.":[260]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1968162177","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
